SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (964)7/19/2000 2:26:10 PM
From: George Mc Geary  Read Replies (1) | Respond to of 1321
 
Ian, Just called my broker and they told me that Merrill, yesterday came out with a price target of 125$ for 12/2001. Wow what a gain today 10+ points. Maybe another 10 points b4 earnings announcement, I hope.



To: Ian@SI who wrote (964)7/20/2000 8:11:56 PM
From: Zeev Hed  Read Replies (1) | Respond to of 1321
 
OT to Ian, I think that MSFT at a market cap of close to $400 B and annual sales in the next two years not exceeding $40 B is priced for perfection. The last Q was far from that, so I think it will linger here a little longer. It is no longer as ig MSFT can grow at 40% per year from here on, IMHO justifying the kind of PE and PSR they have.

Zeev


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News